Product NDC: | 42002-200 |
Proprietary Name: | Visine A |
Non Proprietary Name: | Naphazoline Hydrochloride and Pheniramine Maleate |
Active Ingredient(s): | .25; 3 mg/mL; mg/mL & nbsp; Naphazoline Hydrochloride and Pheniramine Maleate |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42002-200 |
Labeler Name: | Johnson & Johnson Healthcare Products, Division of McNEIL-PPC, Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | NDA020485 |
Marketing Category: | NDA |
Start Marketing Date: | 20101215 |
Package NDC: | 42002-200-13 |
Package Description: | 2 BOTTLE in 1 CARTON (42002-200-13) > 15 mL in 1 BOTTLE |
NDC Code | 42002-200-13 |
Proprietary Name | Visine A |
Package Description | 2 BOTTLE in 1 CARTON (42002-200-13) > 15 mL in 1 BOTTLE |
Product NDC | 42002-200 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Naphazoline Hydrochloride and Pheniramine Maleate |
Dosage Form Name | LIQUID |
Route Name | OPHTHALMIC |
Start Marketing Date | 20101215 |
Marketing Category Name | NDA |
Labeler Name | Johnson & Johnson Healthcare Products, Division of McNEIL-PPC, Inc. |
Substance Name | NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE |
Strength Number | .25; 3 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes |